|
The Immunohistochemistry Antibody Company
|
- Home
-
Products
- All Antibodies
- IHC-plus Antibodies
-
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
- Distributors
-
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
-
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us
|
|
General Cancer Screen 19 Tissue Microarray - LS-SCA19
This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.
|
|
| Catalog ID: |
LS-SCA19 |
| Product Name: |
General Cancer Screen 19 |
| Description: |
Top 4 types of cancer (colon, breast, prostate, and lung) and and normal/non-neoplastic specimens |
| Format: |
FFPE |
| Category: |
Human Multi-Tumor and Normal |
| QA/QC: |
H&E reviewed; IHC validated with a positive control antibody |
| Storage: |
Short term RT; Long term 4ºC |
| Clinical History: |
No |
| Tissue Marker: |
No |
| Stage/Grade: |
Yes |
| Core Diameter: |
1.5 mm |
| Core Thickness: |
5 µm |
| Cases: |
24 |
| Cores: |
48 |
| Slides Per Set: |
1 |
LS-SCA19 Tissue Microarray Map
Slide Number 1
| LABEL | | | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | | A | Bst | Bst | Col | Col | Lng | Lng | Pst | Pst | | B | Bst | Bst | Col | Col | Lng | Lng | Pst | Pst | | C | Bst | Bst | Col | Col | Lng | Lng | Pst | Pst | | D | Bst | Bst | Col | Col | Lng | Lng | Pst | Pst | | E | Bst | Bst | Col | Col | Lng | Lng | Pst | Pst | | F | Bst | Bst | Col | Col | Lng | Lng | Pst | Pst |
|
Diagnosis Type Legend| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue LegendBreast (Bst); Breast, Duct (Bst); Colon (Col); Lung (Lng); Prostate (Pst);
LS-SCA19 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type | TNM Tumor Classification | Tumor Grade | Gleason Score |
|---|
| 1 | A1 | Human | F | 51 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N0M0 | 1 | |
| 1 | A2 | Human | F | 51 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N0M0 | 1 | |
| 1 | A3 | Human | F | 75 y | Colon (Col) | Adenocarcinoma, Papillary | Malignant | T2N1M0 | 1 | |
| 1 | A4 | Human | F | 75 y | Colon (Col) | Adenocarcinoma, Papillary | Malignant | T2N1M0 | 1 | |
| 1 | A5 | Human | M | 64 y | Lung (Lng) | Adenocarcinoma | Malignant | T3N1M2 | 1 | |
| 1 | A6 | Human | M | 64 y | Lung (Lng) | Adenocarcinoma | Malignant | T3N1M2 | 1 | |
| 1 | A7 | Human | M | 66 y | Prostate (Pst) | Adenocarcinoma | Malignant | | | |
| 1 | A8 | Human | M | 66 y | Prostate (Pst) | Adenocarcinoma | Malignant | | | |
| 1 | B1 | Human | F | 52 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N0M1 | 2 | |
| 1 | B2 | Human | F | 52 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N0M1 | 2 | |
| 1 | B3 | Human | M | 71 y | Colon (Col) | Adenocarcinoma | Malignant | T2N1M1 | 3 | |
| 1 | B4 | Human | M | 71 y | Colon (Col) | Adenocarcinoma with necrosis | Malignant | | | |
| 1 | B5 | Human | M | 44 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N1M1 | 2 | |
| 1 | B6 | Human | M | 44 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N1M1 | 2 | |
| 1 | B7 | Human | M | 60 y | Prostate (Pst) | Adenocarcinoma | Malignant | T2NxM0 | 3 | 4+4 |
| 1 | B8 | Human | M | 60 y | Prostate (Pst) | Adenocarcinoma | Malignant | T2NxM0 | 3 | 4+4 |
| 1 | C1 | Human | M | 61 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N0M0 | 3 | |
| 1 | C2 | Human | M | 61 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N0M0 | 3 | |
| 1 | C3 | Human | M | 60 y | Colon (Col) | Adenocarcinoma | Malignant | T3N1 | 2 | |
| 1 | C4 | Human | M | 60 y | Colon (Col) | Adenocarcinoma | Malignant | T3N1 | 2 | |
| 1 | C5 | Human | M | 67 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N1M0 | 3 | |
| 1 | C6 | Human | M | 67 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N1M0 | 3 | |
| 1 | C7 | Human | M | 82 y | Prostate (Pst) | Adenocarcinoma | Malignant | T2NxM0 | 3 | 4+5 |
| 1 | C8 | Human | M | 82 y | Prostate (Pst) | Adenocarcinoma | Malignant | T2NxM0 | 3 | 4+5 |
| 1 | D1 | Human | F | 21 y | Breast (Bst) | Normal | Benign non-neoplastic | | | |
| 1 | D2 | Human | F | 21 y | Breast, Duct (Bst) | Normal | Benign non-neoplastic | | | |
| 1 | D3 | Human | M | 30 y | Colon (Col) | Normal | Benign non-neoplastic | | | |
| 1 | D4 | Human | M | 30 y | Colon (Col) | Normal | Benign non-neoplastic | | | |
| 1 | D5 | Human | F | 21 y | Lung (Lng) | Normal | Benign non-neoplastic | | | |
| 1 | D6 | Human | F | 21 y | Lung (Lng) | Normal | Benign non-neoplastic | | | |
| 1 | D7 | Human | M | 43 y | Prostate (Pst) | Normal | Benign non-neoplastic | | | |
| 1 | D8 | Human | M | 43 y | Prostate (Pst) | Normal | Benign non-neoplastic | | | |
| 1 | E1 | Human | F | 21 y | Breast (Bst) | Normal | Benign non-neoplastic | | | |
| 1 | E2 | Human | F | 21 y | Breast (Bst) | Normal | Benign non-neoplastic | | | |
| 1 | E3 | Human | M | 40 y | Colon (Col) | Normal | Benign non-neoplastic | | | |
| 1 | E4 | Human | M | 40 y | Colon (Col) | Normal | Benign non-neoplastic | | | |
| 1 | E5 | Human | F | 21 y | Lung (Lng) | Normal | Benign non-neoplastic | | | |
| 1 | E6 | Human | F | 21 y | Lung (Lng) | Normal | Benign non-neoplastic | | | |
| 1 | E7 | Human | M | 40 y | Prostate (Pst) | Normal | Benign non-neoplastic | | | |
| 1 | E8 | Human | M | 40 y | Prostate (Pst) | Normal | Benign non-neoplastic | | | |
| 1 | F1 | Human | F | 15 y | Breast (Bst) | Normal | Benign non-neoplastic | | | |
| 1 | F2 | Human | F | 15 y | Breast (Bst) | Normal | Benign non-neoplastic | | | |
| 1 | F3 | Human | M | 40 y | Colon (Col) | Normal | Benign non-neoplastic | | | |
| 1 | F4 | Human | M | 40 y | Colon (Col) | Normal | Benign non-neoplastic | | | |
| 1 | F5 | Human | M | 35 y | Lung (Lng) | Normal | Benign non-neoplastic | | | |
| 1 | F6 | Human | M | 35 y | Lung (Lng) | Normal | Benign non-neoplastic | | | |
| 1 | F7 | Human | M | 40 y | Prostate (Pst) | Normal | Benign non-neoplastic | | | |
| 1 | F8 | Human | M | 40 y | Prostate (Pst) | Normal | Benign non-neoplastic | | | |
Copyright © 2013 LifeSpan BioSciences, Inc. All Rights Reserved
